CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Lek Pharmaceuticals Dd's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
Mar 6, 2019New Process For The Synthesis Of 1-(2-((2,4-Dimethylphenyl)Thio)Phenyl)Piperazine2
Feb 27, 2019A Method For Controlling The Main Complex N-Glycan Structures And The Acidic Variants And Variability In Bioprocesses Producing Recombinant Proteins2
Jan 24, 2018Production Of Glycoproteins With Low N-Glycolylneuraminic Acid (Neu5Gc) Content1